virginiamycin and Chronic-Disease

virginiamycin has been researched along with Chronic-Disease* in 5 studies

Other Studies

5 other study(ies) available for virginiamycin and Chronic-Disease

ArticleYear
[Persistent bacteremia caused by methicillin-resistant Staphylococcus aureus].
    Enfermedades infecciosas y microbiologia clinica, 2008, Volume: 26, Issue:9

    Topics: Aged; Bacteremia; Catheterization, Central Venous; Chronic Disease; Daptomycin; Discitis; Humans; Jugular Veins; Male; Methicillin-Resistant Staphylococcus aureus; Pancreatitis; Rifampin; Staphylococcal Infections; Vancomycin; Virginiamycin

2008
Quinupristin/dalfopristin and voriconazole controlled Staphylococcus epidermidis pneumonia and chronic necrotizing aspergillosis in a patient with severe lung degradation consequent to multiple treatments for Hodgkin's lymphoma.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2006, Volume: 12, Issue:6

    We report here a 34-year-old woman with complicated severe opportunistic pulmonary infection, who was treated with the newly developed antibiotics quinupristin/dalfopristin (QPR/DPR) and voriconazole. She had received repeated chemotherapy, irradiation of the left lung, autologous and allogeneic bone marrow transplantation (BMT), and segmentectomy of the base of the left lung as treatments for Hodgkin's lymphoma. Although she had been in complete remission (CR), the structure of the left lung was severely degraded. Four years after achieving CR, she developed complicated life-threatening pulmonary infections with methicillin-resistant Staphylococcus epidermidis and Aspergillus niger during outpatient care. Chemotherapies with QPR/DPR for S. epidermidis pneumonia and voriconazole for chronic necrotizing pulmonary aspergillosis (CNPA) improved her symptoms rapidly without any major complications. QPR/DPR and voriconazole are considered effective for patients with life-threatening opportunistic pulmonary infections who have previously been treated with intensive regimens including radiotherapies to the lung.

    Topics: Adult; Anti-Bacterial Agents; Antifungal Agents; Aspergillosis; Aspergillus niger; Chronic Disease; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Lung Diseases, Fungal; Lymphatic Irradiation; Necrosis; Pneumonia, Bacterial; Pyrimidines; Radiation Injuries; Radiography; Staphylococcal Infections; Staphylococcus epidermidis; Triazoles; Virginiamycin; Voriconazole

2006
[Clinical and experimental study on the use of staphylomycin in kidney and urinary tract infections].
    Minerva medica, 1973, Sep-15, Volume: 64, Issue:64

    Topics: Adolescent; Adult; Aged; Child; Chronic Disease; Drug Evaluation; Female; Humans; Kidney Diseases; Male; Microbial Sensitivity Tests; Middle Aged; Regression Analysis; Staphylococcal Infections; Staphylococcus; Urinary Tract Infections; Virginiamycin

1973
[Therapeutic action of a new antibiotic-corticoid association used for instillations in otology].
    Annales d'oto-laryngologie et de chirurgie cervico faciale : bulletin de la Societe d'oto-laryngologie des hopitaux de Paris, 1969, Volume: 86, Issue:9

    Topics: Acute Disease; Anti-Bacterial Agents; Chronic Disease; Dexamethasone; Ear Canal; Eczema; Humans; Otitis; Otitis Externa; Polymyxins; Virginiamycin

1969
[Clinical experiences in the antibiotic treatment of secondary chronic osteomyelitis].
    Medizinische Klinik, 1968, Jun-14, Volume: 63, Issue:24

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Chronic Disease; Drug Resistance, Microbial; Female; Fractures, Bone; Humans; Male; Middle Aged; Osteomyelitis; Staphylococcal Infections; Staphylococcus; Virginiamycin

1968